New York ADAP to cover new AIDS drugs plus viral load testing.
Link
D
D
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy*; D000903:Antibiotics, Antineoplastic / Q000191:economics / Q000627:therapeutic use; D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000188:drug therapy; D003630:Daunorubicin / Q000191:economics / Q000627:therapeutic use; D016527:Drug Costs; D006678:HIV / Q000302:isolation & purification*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D008119:Lobbying; D019829:Nevirapine; D009518:New York; D011725:Pyridines / Q000191:economics / Q000627:therapeutic use; D012514:Sarcoma, Kaposi / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D011725:Pyridines; D019829:Nevirapine; D003630:Daunorubicin